MétaCan
Menu
Back to cohort
Record W7117265112 · doi:10.1002/alz70859_103238

Exploring the Effects of Phospholipase A2 Inhibition on Brain Metabolism and Pathology in a Rat Model of Alzheimer’s Disease

2025· article· en· W7117265112 on OpenAlexaff
Emily Hiles, Colleen Bailey, Wendy Oakden, Tina L. Beckett, Mary Hill, JoAnne McLaurin, Jamie Near

Bibliographic record

VenueAlzheimer s & Dementia · 2025
Typearticle
Languageen
FieldNeuroscience
TopicNeurological Disorders and Treatments
Canadian institutionsSunnybrook Health Science CentreSunnybrook HospitalUniversity of Toronto
Fundersnot available
KeywordsPhospholipase A2Rat modelDiseaseMetabolismAnimal modelCholine

Abstract

fetched live from OpenAlex

BACKGROUND: Magnetic resonance spectroscopy (MRS) offers a non-invasive modality to explore metabolic changes associated with Alzheimer's disease (AD) pathogenesis and treatment efficacy. Studies in both humans and animal models have observed elevated choline in AD which may suggest an increase in cell membrane breakdown by phospholipase A2 (PLA2). PLA2 has also been linked to multiple hallmarks of AD pathology such as cognitive decline and inflammation (Figure 1). We hypothesized that PLA2 inhibition will reduce elevated choline levels and improve AD pathology. METHOD: TgF344-AD rats (Tg) and non-transgenic (NTg) litter mates at 14 months old (N=50) were treated via daily IP injections with either 5mg/kg mepacrine (a global PLA2 inhibitor) or saline for one week followed by injections every other day for two weeks. Metabolite concentrations were measured in the right dorsal hippocampus (HC) and pre-frontal cortex (PFC) using localized proton MRS (Figure 2A) at baseline, 7 days, and 21 days. After 7 days of treatment, animals completed the Barnes maze including acquisition training, long-term memory probe (Figure 3A), and reversal training. At day 21, animals were sacrificed, tissues were collected, and brain sections were stained with 6F3D, PHF1, IBA1, and GFAP to observe changes to hippocampal pathology with PLA2 inhibition. RESULT: At baseline, choline concentration was significantly elevated in the HC (6.8±1.9% increase, P=0.0012) but not the PFC (3.4±2.3% increase, P=0.1426; Figure 2B) of Tg animals. These levels were significantly reduced at day 7 and 21 of treatment in the HC of mepacrine treated Tg animals (6.6±1.9% decrease, P=0.0141; 6.9±1.3% decrease, P=0.0012; Figure 2B). In the PFC of mepacrine treated Tg animals, choline levels were only significantly reduced by day 21 of treatment (8.1±1.8% decrease, P=0.0027; Figure 2B). Contrary to our hypothesis, no significant differences were observed between saline and mepacrine treated Tg animals in any of the parameters measured in the probe trail (Figure 3B-F). Pathology data is currently being analyzed. CONCLUSION: These findings indicate choline concentration is associated with PLA2 activity in AD. However, changes to spatial memory formation with PLA2 inhibition were not observed. This is contrary to the literature; thus, further research is needed to understand if PLA2 plays a role in AD associated memory impairment.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.005

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0010.002
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.058
GPT teacher head0.276
Teacher spread0.218 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueAlzheimer s & DementiaSame topicNeurological Disorders and TreatmentsFrench-language works237,207